ArticleJournal of family medicine and primary care2026
Evaluation of the National Viral Hepatitis Control Program in Uttarakhand: A mixed-method approach.
Article in Journal of family medicine and primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Conforming to the global commitment of combating viral hepatitis by 2030, India launched the National Viral Hepatitis Control Program (NVHCP) in 2018. NVHCP is a comprehensive strategy that uses a cascade of care approach to tackle all forms of viral hepatitis. This study was conceptualized to assess the implementation status of NVHCP and to understand the key stakeholders' perspective on prevention, screening, diagnosis, and treatment of viral hepatitis in Uttarakhand. Material and Methods: The study commenced in July 2021 and was conducted over a year in six districts of Uttarakhand. The program was evaluated using a sequential explanatory mixed-method approach with a pragmatic stance, incorporating a quantitative component of record-based analysis and a qualitative component of key informant interviews (KIIs) with program managers, physicians, and laboratory technicians. Results: NVHCP integrated effectively with the preexisting healthcare infrastructure and programs to provide primary and secondary levels of prevention. The program picked up pace initially by identifying the service delivery points, training the nominated personnel, and supplying logistics for screening and treatment. However, the developments were halted by the COVID-19 pandemic, which ensued shortly after the first NVHCP budget allocation. From 2019-20 to 2020-21, the pandemic resulted in a 73% decline in hepatitis B virus (HBV) screening and a 76% decline in hepatitis C virus (HCV) screening. The biggest missing link in the cascade of care for HCV was the nonavailability of PCR-based diagnostic viral load testing at treatment centers. A lack of a dedicated data management portal, an inefficient supply chain, and a lack of nomination of pharmacists and peer support were some of the gaps that could be addressed to accelerate the elimination process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.